Mbd3 Promotes Reprogramming of Primary Human Fibroblasts.

Int J Stem Cells

Department of Haematology, University College London, Cancer Institute, London, UK.

Published: November 2018

Mbd3 (Methyl-CpG binding domain protein), a core member of NuRD (nucleosome remodelling and deacetylation) is essential for embryogenesis. However, its role in reprogramming of somatic cells into induced pluripotent stem cells (iPSC) remains controversial. Some reports suggest that Mbd3 inhibits pluripotency, whilst others show that it greatly enhances reprogramming efficiency. Our study is the first to assess the role of on reprogramming of primary human fibroblasts using Yamanaka episomal plasmids (Reprogramming factors (RF) under feeder-free conditions. We showed that shRNA-mediated partial depletion of resulted in >5-fold reduction in the efficiency of reprogramming of primary human fibroblasts. Furthermore, iPSC that emerged after knock-down of were incapable of trilineage differentiation even though they expressed all markers of pluripotency. In contrast, over-expression of the isoform along with the Yamanaka episomal plasmids increased the number of fibroblast derived iPSC colonies by at least two-fold. The resulting colonies were capable of trilineage differentiation. Our results, therefore, suggest that appears to play an important role in reprogramming of primary human fibroblasts, which provides further insight into the biology of reprogramming but also has direct implication for translation of iPSC to clinic.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6285286PMC
http://dx.doi.org/10.15283/ijsc18036DOI Listing

Publication Analysis

Top Keywords

reprogramming primary
16
primary human
16
human fibroblasts
16
role reprogramming
12
reprogramming
8
yamanaka episomal
8
episomal plasmids
8
trilineage differentiation
8
mbd3 promotes
4
promotes reprogramming
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!